The past week has brought a steady flow of signals from major global regulators, offering a snapshot of how oversight is ...

Dutch clinical-stage cancer drug developer Merus, which is developing innovative, full-length multi-specific antibodies and ...

US genetic medicine company Sarepta Therapeutics has announced an update to the prescribing information for Elevidys ...

Canada-based clinical-stage biotech Zymeworks today announced positive top-line results from the Phase III HERIZON-GEA-01 ...

Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is ...

Belgium-based Agomab Therapeutics today announced positive data from 103 participants completing 12 weeks of treatment in the ...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, today announced the close ...

Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million ...

The European Federation of Pharmaceuticals Industries and Associations (EFPIA) and Vaccine Europe (VE) are calling for clear, ...

Last week saw the end of the bidding war for Metsera, with the company accepting an improved offer from Pfizer and counter ...

Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the ...

The European Medicines Agency’s EMA’s human medicines committee (CHMP) recommended seven novel medicines for approval at its ...